Scientific Session VI: Neurotrauma

Monday, April 15 | 2:30 pm - 6:00 pm | 30AB; SDCC

Moderator(s): Nicholas James Brandmeir, MD; Jack I. Jallo, MD, PhD, FAANS

Supported by an educational grant from Codman Specialty Surgical, a Division of Integra LifeSciences

2:30 pm - 2:32 pm

Introduction: Chuck Noll Lecture

Julian E. Bailes Jr., MD, FAANS

Joseph Maroon, MD, FAANS(L), is regarded as a premiere specialist in the surgical treatment of injuries and diseases of the brain and spine, specializing in minimally invasive procedures. He has an international referral base, including numerous professional athletes and celebrities. He has conducted extensive research into neurotrauma, brain tumors and diseases of the spine, which has led to many innovative techniques for diagnosing and treating these disorders. His research efforts have garnered him numerous awards from various national and international neurological societies.

3:34 pm - 3:35 pm

Introduction: Point-Counter Point: Guidelines versus Clinical Experience for the Management of Severe TBI

Jack I. Jallo, MD, PhD, FAANS

3:36 pm - 3:49 pm

Point-Counter Point: The Case for Guideline-based Management

Jamshid Ghajar, MD, PhD, FAANS

3:50 pm - 4:03 pm

Point-Counter Point: The Case for Clinical Experience

Franco Servadei, MD (Italy)

4:04 pm - 4:34 pm

Beverage Break in the Exhibit Hall

4:35 pm - 4:37 pm

Introduction: Marmarou Lecture

Martina Stippler, MD, FAANS

4:38 pm - 5:10 pm

Thomas P Bleck MD MCCM FNCS is professor of neurological sciences, neurosurgery, internal medicine and anesthesiology at Rush University Medical Center, where he is a neurointensivist and the director of clinical neurophysiology. He is also the founding president Neurocritical Care Society. In 2015, the American College of Critical Care Medicine and the SCCM elected him a Master of Critical Care Medicine; there are 82 masters out of nearly 18,000 members. Dr. Bleck’s research interests include subarachnoid hemorrhage, intracerebral hemorrhage, head injury, status epilepticus, infections, neuromuscular respiratory failure and the ICU management of the organ donor. He has been involved in therapeutic temperature modulation research since 1999.